Newspaper Publication - Extract of Audited Financial Results for the quarter and Financial year ended on 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adline Chem Lab Ltd submitted a newspaper advertisement (published in Indian Express and Financial Express) containing the extract of its audited financial results for the quarter and full year ended March 31, 2025, as required under SEBI listing rules. Total income from operations for FY25 stood at Rs. 24.89 lacs compared to just Rs. 0.01 lacs in FY24, while Q4 FY25 alone generated the entire Rs. 24.89 lacs. The company posted a net profit after tax of Rs. 20.94 lacs in Q4 FY25, swinging from a loss of Rs. 8.77 lacs in Q4 FY24, but for the full year FY25 it still reported a net loss of Rs. 13.22 lacs (vs. Rs. 27.18 lacs loss in FY24). Basic and diluted EPS for FY25 stood at Rs. -0.02, with equity share capital unchanged at Rs. 585 lacs and other equity at nil.
This is a routine regulatory newspaper publication of already-approved audited results and does not itself move the stock. For shareholders, the takeaway is that the company's scale of operations is extremely small, full-year losses persist despite a Q4 profit, and there is no disclosed reserves buffer, making this a very high-risk, thinly-traded micro-cap.